Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Itri

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cancer|August 15, 1992
The interferonsL M Itri
Seminars in Oncology|June 10, 2000
Optimal hemoglobin levels for cancer patientsL M Itri
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapyL M Itri
Cancer Investigation|January 1, 1990
Interferon combinations in cancer therapyL M Itri
Cancer|December 1, 1993
Cancer chemopreventionL M Itri
Cancer Treatment Reports|November 1, 1987
Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancerS M Grunberg, L M Itri
Cancer Treatment Reviews|June 1, 1982
A review of etoposide in patients with non-small-cell lung cancer (NSCLC)L M Itri, R J Gralla
Seminars in Hematology|July 1, 1988
Anti-interferon antibodies: a perspectiveR A Figlin, L M Itri
The Oncologist|May 25, 1999
Cancer-related fatigue: guidelines for evaluation and managementR K Portenoy, L M Itri
Cancer|April 15, 1986
Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patientsG J Jones, L M Itri
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cancer|August 15, 1992
The interferonsL M Itri
Seminars in Oncology|June 10, 2000
Optimal hemoglobin levels for cancer patientsL M Itri
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapyL M Itri
Cancer Investigation|January 1, 1990
Interferon combinations in cancer therapyL M Itri
Cancer|December 1, 1993
Cancer chemopreventionL M Itri
Cancer Treatment Reports|November 1, 1987
Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancerS M Grunberg, L M Itri
Cancer Treatment Reviews|June 1, 1982
A review of etoposide in patients with non-small-cell lung cancer (NSCLC)L M Itri, R J Gralla
Seminars in Hematology|July 1, 1988
Anti-interferon antibodies: a perspectiveR A Figlin, L M Itri
The Oncologist|May 25, 1999
Cancer-related fatigue: guidelines for evaluation and managementR K Portenoy, L M Itri
Cancer|April 15, 1986
Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patientsG J Jones, L M Itri
Pageof 5